SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 23rd, 2019 • Biolargo, Inc. • Chemicals & allied products • New York
This securities purchase agreement (the “Agreement”), dated as of April 18, 2019, by and between BioLargo, Inc., a Delaware corporation, with headquarters located at 14921 Chestnut St. Westminster, CA, 92683 (the “Company”), and Bellridge Capital LP, a Delaware company with its office at 515 E. Las Olas Boulevard, Suite 120A Fort Lauderdale, Florida 33301 (the “Buyer”).
10% Convertible NOTEConvertible Security Agreement • April 23rd, 2019 • Biolargo, Inc. • Chemicals & allied products • New York
THIS 10% CONVERTIBLE NOTE is one of a series of duly authorized and validly issued 10% Convertible Notes issued at a 10% original issue discount by BioLargo, Inc., a Delaware corporation (the “Company”) (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).
